Which induction chemotherapy regimen followed by cisplatin-based concurrent chemoradiotherapy is the best choice among PF, TP and TPF for locoregionally advanced nasopharyngeal carcinoma?

He, Yan; Guo, Tao; Wang, Jingjing; Sun, Yu; Guan, Hui; Wu, Shaoyong; Peng, Xingchen

He, Yan; Guo, Tao; Wang, Jingjing; Sun, Yu; Guan, Hui; Wu, Shaoyong; Peng, Xingchen.

Afiliación

He Y; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Guo T; Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Wang J; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Sun Y; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Guan H; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Wu S; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Peng X; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.

Ann Transl Med ; 7(5): 104, 2019 Mar.

Article en En | MEDLINE | ID: mdl-31019954

Palabras clave

Nasopharyngeal carcinoma (NPC); chemoradiotherapy; induction chemotherapy regimen (IC regimen); network meta-analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Ann Transl Med Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google